Scholar Rock Holding Corp (SRRK)
9.45
+0.02
(+0.21%)
USD |
NASDAQ |
Jun 14, 16:00
9.45
0.00 (0.00%)
After-Hours: 20:00
Scholar Rock Price to Book Value: 4.124 for June 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 4.124 |
| June 13, 2024 | 4.115 |
| June 12, 2024 | 4.097 |
| June 11, 2024 | 4.233 |
| June 10, 2024 | 4.202 |
| June 07, 2024 | 4.150 |
| June 06, 2024 | 4.115 |
| June 05, 2024 | 4.289 |
| June 04, 2024 | 4.276 |
| June 03, 2024 | 4.137 |
| May 31, 2024 | 4.097 |
| May 30, 2024 | 4.097 |
| May 29, 2024 | 4.019 |
| May 28, 2024 | 4.508 |
| May 24, 2024 | 4.656 |
| May 23, 2024 | 4.708 |
| May 22, 2024 | 5.110 |
| May 21, 2024 | 5.354 |
| May 20, 2024 | 5.463 |
| May 17, 2024 | 5.450 |
| May 16, 2024 | 6.249 |
| May 15, 2024 | 6.126 |
| May 14, 2024 | 6.113 |
| May 13, 2024 | 5.952 |
| May 10, 2024 | 5.825 |
| Date | Value |
|---|---|
| May 09, 2024 | 6.349 |
| May 08, 2024 | 6.327 |
| May 07, 2024 | 6.410 |
| May 06, 2024 | 6.572 |
| May 03, 2024 | 6.698 |
| May 02, 2024 | 6.589 |
| May 01, 2024 | 6.528 |
| April 30, 2024 | 6.401 |
| April 29, 2024 | 6.497 |
| April 26, 2024 | 6.340 |
| April 25, 2024 | 6.091 |
| April 24, 2024 | 6.148 |
| April 23, 2024 | 6.453 |
| April 22, 2024 | 6.108 |
| April 19, 2024 | 6.043 |
| April 18, 2024 | 6.086 |
| April 17, 2024 | 5.977 |
| April 16, 2024 | 6.108 |
| April 15, 2024 | 5.816 |
| April 12, 2024 | 5.868 |
| April 11, 2024 | 6.182 |
| April 10, 2024 | 6.117 |
| April 09, 2024 | 6.466 |
| April 08, 2024 | 6.326 |
| April 05, 2024 | 6.278 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8353
Minimum
Jul 01 2022
27.55
Maximum
Dec 23 2020
4.498
Average
3.899
Median
May 20 2021
Price to Book Value Benchmarks
| Amgen Inc | 31.90 |
| Eli Lilly and Co | 65.16 |
| Pfizer Inc | 1.690 |
| Ocular Therapeutix Inc | 2.183 |
| X4 Pharmaceuticals Inc | 165.34 |
Price to Book Value Related Metrics
| PS Ratio | 17.46 |
| PEG Ratio | -1.859 |
| Price | 9.45 |
| Earnings Yield | -22.12% |
| Market Cap | 753.68M |
| PEGY Ratio | -1.859 |